About this trial
PHAGEinLYON Clinic cohort study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients with a severe infection treated with bacteriophage in the Hospices civils de Lyon from 2015 to 2033. The primary objective is to describe the severe infections treated with phagotherapy. 250 patients will be included in the study.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient with severe infection treated with bacteriophage in the Hospices Civils de Lyon from 01/01/2015 to 01/01/2033
PHAGEinLYON Clinic cohort study information notice provided to the patient
Disqualifiers
Opposition of trial participant
Trial population
250 patients with severe infection treated with phagotherapy will be included in the study.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Description of severe infection
Other interventionDescription of severe infections treated with bacteriophage in the Hospices Civils de Lyon from 2015 to 2033.
Treatment groups
Trial outcomes
Primary outcomes
Rate of each type of severe infection
Rate of each type of severe infection treated with bacteriophage in the Hospices Civils de Lyon from 2015 to 2033.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.